Cargando…
Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out
BACKGROUND: Oral daily preexposure prophylaxis (PrEP) using emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) is recommended as standard of care for prevention in individuals at high risk for HIV infection, including pregnant and postpartum cisgender women. FTC/TDF is also active against hepat...
Autores principales: | Joseph Davey, Dvora, Hsiao, Nei-yuan, Wendy Spearman, C., Sonderup, Mark, Hu, Nai-Chung, Mashele, Nyiko, Mvududu, Rufaro, Myer, Landon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438249/ https://www.ncbi.nlm.nih.gov/pubmed/36050648 http://dx.doi.org/10.1186/s12879-022-07697-5 |
Ejemplares similares
-
Early pre‐exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa
por: Joseph Davey, Dvora Leah, et al.
Publicado: (2022) -
Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence
por: Moran, Alexander, et al.
Publicado: (2021) -
Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa
por: Khadka, Nehaa, et al.
Publicado: (2023) -
Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa
por: Beesham, Ivana, et al.
Publicado: (2022) -
Pre-exposure Prophylaxis Recent Adherence With Real-Time Adherence Feedback and Partner Human Immunodeficiency Virus Self-Testing: A Pilot Trial Among Postpartum Women
por: Joseph Davey, Dvora Leah, et al.
Publicado: (2021)